The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Overtreatment of low-risk prostate cancer in the United States: Incidence, cost, complications, and implications for the screening debate.
Ayal A. Aizer
No relevant relationships to disclose
Xiangmei Gu
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Neil E. Martin
No relevant relationships to disclose
Jim C. Hu
No relevant relationships to disclose
Paul Linh Nguyen
No relevant relationships to disclose